2 ML digoxin 0.25 MG/ML Injection — RxCUI 104208
RxNorm drug concept · Semantic clinical drug
RxCUI 104208
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
11 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI104208
Official name2 ML digoxin 0.25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdigoxin 500 MCG per 2 ML Injection; digoxin 500 MCG in 2 ML Injection
FDA products mapped12
Package NDCs mapped11
Reported Medicaid activity (SDUD)189 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Digoxin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats mild to moderate heart failure in adults and helps control the heart rate in chronic atrial fibrillation. It is also used in children with heart failure. It can ease symp...
- Take it exactly as your prescriber directs, at about the same time each day. Tablets can be taken with or after meals, but try to be consistent. Avoid high-bran meals around your d...
- Nausea, vomiting, loss of appetite, diarrhea, dizziness, headache and tiredness are among the more common ones. Call me or your doctor if you notice vision changes like blurred or...
- Many medicines interact with digoxin. Heart rhythm drugs, some antibiotics and antacids are common examples, and St. John’s Wort can lower digoxin levels. Always check with me befo...
🕸️ Concept Web — How 2 ML digoxin 0.25 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML digoxin 0.25 MG/ML Injection
RxCUI 104208 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Digoxin
3407IN
-
Digoxin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lanoxin
202988BN
-
Lanoxin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Digoxin Injection
1743558SCDF -
Digoxin Injectable Product
1151519SCDG -
Digoxin Injection [Lanoxin]
1743560SBDF -
Lanoxin Injectable Product
1175613SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Digoxin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Digoxin 0.25 MG/ML
315822SCDC -
2 ML digoxin 0.25 MG/ML Injection [Lanoxin]
208137SBD -
Digoxin 0.25 MG/ML [Lanoxin]
568863SBDC
-
Digoxin 0.25 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Digoxin 0.25 MG/ML
SCDC · 315822 -
Digoxin Injection
SCDF · 1743558 -
Digoxin Injectable Product
SCDG · 1151519
Brand-Name Concepts
-
2 ML digoxin 0.25 MG/ML Injection [Lanoxin]
SBD · 208137 -
Digoxin 0.25 MG/ML [Lanoxin]
SBDC · 568863 -
Digoxin Injection [Lanoxin]
SBDF · 1743560 -
Lanoxin Injectable Product
SBDG · 1175613 -
Lanoxin
BN · 202988
📦 FDA Products & Package NDCs
12 products · 11 package NDCs
11 package NDCs map to RxCUI 104208 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9850-02 | 1 AMPULE in 1 BAG (0404-9850-02) / 2 mL in 1 AMPULE | Digoxin | Henry Schein, Inc. | 2022-01-10 |
| 00641-1410-35 | 25 AMPULE in 1 CARTON (0641-1410-35) / 2 mL in 1 AMPULE (06... | Digoxin | Hikma Pharmaceuticals USA Inc. | 1975-10-24 |
| 00641-6184-25 | 25 AMPULE in 1 CARTON (0641-6184-25) / 2 mL in 1 AMPULE (06... | Digoxin | Hikma Pharmaceuticals USA Inc. | 1975-10-24 |
| 00781-3059-95 | 10 AMPULE in 1 CARTON (0781-3059-95) / 2 mL in 1 AMPULE (07... | Digoxin | Sandoz Inc | 2003-08-21 |
| 51662-1217-01 | 2 mL in 1 AMPULE (51662-1217-1) | DIGOXIN | HF Acquisition Co LLC, DBA HealthFirst | 2018-09-13 |
| 51662-1217-03 | 25 POUCH in 1 CASE (51662-1217-3) / 1 mL in 1 POUCH (51662-... | DIGOXIN | HF Acquisition Co LLC, DBA HealthFirst | 2021-01-12 |
| 55154-5106-05 | 5 AMPULE in 1 BAG (55154-5106-5) / 2 mL in 1 AMPULE | Digoxin | Cardinal Health 107, LLC | 2011-06-28 |
| 70515-0261-10 | 10 VIAL in 1 BOX (70515-261-10) / 2 mL in 1 VIAL | LANOXIN | Covis Pharma US, Inc | 2019-10-29 |
| 70515-0263-10 | 10 VIAL in 1 BOX (70515-263-10) / 1 mL in 1 VIAL | LANOXIN | Covis Pharma US, Inc | 2019-10-29 |
| 71872-7325-01 | 1 AMPULE in 1 BAG (71872-7325-1) / 2 mL in 1 AMPULE | Digoxin | Medical Purchasing Solutions, LLC | 2024-05-29 |
| 84549-0410-35 | 2 mL in 1 AMPULE (84549-410-35) | Digoxin | ProPharma Distribution | 2025-12-11 |
Observed labelers:
Covis Pharma US, Inc (2) ·
HF Acquisition Co LLC, DBA HealthFirst (2) ·
Hikma Pharmaceuticals USA Inc. (2) ·
Cardinal Health 107, LLC (1) ·
Henry Schein, Inc. (1) ·
Medical Purchasing Solutions, LLC (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1160 | Digoxin injection | 8 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.